A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
about
SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancerMicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4Semi-supervised learning for potential human microRNA-disease associations inferenceAssociation between risk of oral precancer and genetic variations in microRNA and related processing genes.Pri-miR-34b/c rs4938723 TC heterozygote is associated with increased cancer risks: evidence from published data.Single-nucleotide polymorphisms among microRNA: big effects on cancer.An updated meta-analysis of 23 case-control studies on the association between miR-34b/c polymorphism and cancer riskPri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations.Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls.Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population.The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases.Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk.The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma.Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma riskLack of association of MiR-34b/c polymorphism (rs4938723) with hepatocellular carcinoma: a meta-analysisTP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.The interaction effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 gene polymorphisms in gastric cancer and atrophic gastritis.A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population.A new polymorphism biomarker rs629367 associated with increased risk and poor survival of gastric cancer in chinese by up-regulated miRNA-let-7a expressionThe "Macro" World of microRNAs in Hepatocellular Carcinoma.Association between miR34b/c polymorphism rs4938723 and cancer risk: a meta-analysis of 11 studies including 6169 cases and 6337 controls.Noncoding RNA as therapeutic targets for hepatocellular carcinoma.MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON ConsortiumFunctional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.High USP22 expression indicates poor prognosis in hepatocellular carcinoma.SNP Regulation of microRNA Expression and Subsequent Colon Cancer RiskAssociation between two genetic variants in miRNA and primary liver cancer risk in the Chinese population.Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm.Evaluation of a novel functional single-nucleotide polymorphism (rs35010275 G>C) in MIR196A2 promoter region as a risk factor of gastric cancer in a Chinese population.Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.Genetic polymorphisms in apoptosis-related genes and the prognosis of hepatocellular carcinoma.Mechanistic insights into the role of microRNAs in cancer: influence of nutrient crosstalk.Genetic variants in pseudogene E2F3P1 confer risk for HBV-related hepatocellular carcinoma in a Chinese population.Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer riskNew insights on the role of epigenetic alterations in hepatocellular carcinoma.Pri-let-7a-1 rs10739971 polymorphism is associated with gastric cancer prognosis and might affect mature let-7a expression.A functional variant rs353292 in the flanking region of miR-143/145 contributes to the risk of colorectal cancerAssociations of miR-499 and miR-34b/c Polymorphisms with Susceptibility to Hepatocellular Carcinoma: An Evidence-Based Evaluation.A genetic variant in the promoter region of miR-106b-25 cluster predict clinical outcome of HBV-related hepatocellular carcinoma in Chinese.
P2860
Q26829794-B7968201-AFF2-449D-BE03-AAF51EA4A576Q28118775-18A31B2F-53A4-4424-875E-9754B5A20269Q28656510-F16750CB-FB3E-4038-B33E-80ED59A9931AQ30487016-E052661E-582F-4A81-A54F-48B354D22BB6Q30848691-B1297F5C-32AB-4FF3-8292-269C75FE25E8Q33579702-6560C34C-7CE5-4DE8-BE2C-7C176031A944Q33709940-B118B30E-5657-4851-A075-E80AA090903FQ33778961-F1253811-203F-42BA-B420-F62CDC76640AQ33827330-5F2BBE66-2DB9-49EA-90F8-0A4231269159Q33888370-8B53A1C9-8D9E-47AA-BEAB-2B3C14620E4BQ34380438-F20C6620-E627-4BDC-922E-6BE93E98731BQ34506180-3DE047BC-7244-4D85-A543-B1575633F321Q34525363-2FB6F55A-C765-4CC7-9AB9-7DDA18254AD3Q34629791-B0E7AF12-09F0-43AA-B728-9C9E34487A42Q34918370-E212704D-2099-4239-9B6B-374FD2891DC0Q35077721-E0D1F82F-4C09-4C8A-814E-59D05AEB0C1CQ35106850-CE1BAAA7-ABEA-496A-8A5F-A298FDF074B0Q35153904-3CCA7879-78A3-410A-A17D-EC4674D715A3Q35156184-71584F51-54B2-4E6D-BEF9-BB703B26DB5CQ35215896-4B01B88D-9687-414B-A128-6B432B9DC125Q35345374-E6B74DD9-C2CC-408A-82E7-7012D8A1D3A9Q35592207-50042115-8EB7-4DEC-94A0-AF33A4403C13Q35651285-166B97C1-2C50-4B26-A34C-BD2A3B7515FBQ35709727-51529E17-AB02-4AEE-9D98-093CE0F18C47Q35781438-EF4C0797-621E-4CFF-881F-B9FBC8F69A52Q35828647-B3B8F4B8-0287-4BA6-B051-32DA4630F07BQ35859001-4A9DC00C-6C1A-4393-AD4E-D13F4AF5556CQ35878356-EEDC13E4-7704-4ECD-90D4-3BF4850B542DQ36111357-608949F4-57A0-4182-9DC0-00A61499A1D0Q36193792-6A10ADA7-642A-4200-A830-8CAF4BE597AAQ36255905-34E8B22B-F737-4649-9DB7-B6221F966517Q36309446-8925F9F1-DA2C-4E22-A838-321763001DFDQ36492992-C7061374-5B6D-4B1B-ADEA-85DE734FBF9DQ36878120-97B533DC-CFC0-48F8-B69C-A287E73E9CFAQ37001437-4ECDB879-EB45-4BCD-98F9-A52EC9B6AB91Q37031728-0B2A8179-D8DC-4003-B37F-EB3B414B6FA6Q37078509-49CB0B67-8D4A-4FCE-A38C-417AA2854959Q37117390-04748369-B48B-4ECF-B879-644F1FB93EC2Q37244374-FD1548B6-C89B-40B2-96E6-E826D4F69E2FQ37453234-41F65584-B240-42DE-80CF-8291D1DBB9CB
P2860
A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A potentially functional polym ...... mary hepatocellular carcinoma.
@en
A potentially functional polym ...... mary hepatocellular carcinoma.
@nl
type
label
A potentially functional polym ...... mary hepatocellular carcinoma.
@en
A potentially functional polym ...... mary hepatocellular carcinoma.
@nl
prefLabel
A potentially functional polym ...... mary hepatocellular carcinoma.
@en
A potentially functional polym ...... mary hepatocellular carcinoma.
@nl
P2093
P356
P1476
A potentially functional polym ...... imary hepatocellular carcinoma
@en
P2093
Haibin Shi
Hongbing Shen
Yixin Zhang
P304
P356
10.1002/IJC.25342
P577
2010-03-22T00:00:00Z